BAC
Bank of America Corporation
BAC has the edge over WRB overall, supported by stronger modeled upside and stronger fundamentals.
WRB
W. R. Berkley Corporation
WRB trails on the overall score without a compensating advantage in the available component scores.
BAC Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
BAC's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like BAC.
WRB Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| N/A | |
| N/A |
WRB's profitability is currently healthy, and its revenue is stable. Free cash flow and net leverage aren't meaningful measures for financial services companies like WRB.
BAC PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.4x | $39.50 | -22% |
| Forward | 10x | $50.51 | — |
| Current | 12x | $50.51 | — |
| Fair | 13x | $53.81 | +6.5% |
| Expensive | 15x | $62.23 | +23% |
Historical ranges are pointers, not guarantees.
BAC's PE is in its fair range at 12x. If earnings grow as analysts expect, today's price would be 10x next year's earnings, in its cheap range.
WRB PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 14x | $66.55 | -14% |
| Fair | 15x | $72.25 | -6.4% |
| Current | 16x | $77.15 | — |
| Forward | 16x | $77.15 | — |
| Expensive | 20x | $94.93 | +23% |
Historical ranges are pointers, not guarantees.
WRB has the edge over BAC in the historical PE scenario, which offers more potential upside but is not a forecast.
BAC Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Moderate |
BAC has the edge over WRB on the outlook, with more favorable valuation and profitability expectations.
WRB Forward outlook
| Metric | Outlook |
|---|---|
| Stable | |
| Growth | |
| Growth | |
| Weakening | |
| Limited | |
| High |
Analysts expect earnings and revenue growth for WRB, but weaker profitability.
BAC Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $4.92 | +17% |
| Q3 2026 | $4.19 | +14% |
| Q2 2026 | $4.34 | +27% |
| Q1 2026 | $4.02 | +20% |
| Q4 2025 | $3.81 | +19% |
| Q3 2025 | $3.66 | +33% |
| Q2 2025 | $3.41 | +20% |
| Q1 2025 | $3.35 | +16% |
| Q4 2024 | $3.21 | +4.2% |
WRB has the stronger earnings trend. Trailing diluted EPS is up 14% for BAC versus WRB up 21%.
WRB Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $4.77 | +0.9% |
| Q3 2024 | $3.90 | +18% |
| Q2 2024 | $3.81 | +26% |
| Q1 2024 | $3.75 | +45% |
| Q4 2023 | $3.37 | +2.4% |
| Q3 2023 | $3.30 | +6.8% |
| Q2 2023 | $3.03 | -4.1% |
| Q1 2023 | $2.59 | -22% |
| Q4 2022 | $3.29 | +35% |
WRB's earnings per share have climbed steadily: $4.73 over the past year, up 21% from the year before, and higher year over year for nine quarters in a row.
BAC Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $30B | +6.7% |
| Q2 2026 | $31.6B | +19% |
| Q1 2026 | $30.3B | +11% |
| Q4 2025 | $31.2B | +23% |
| Q3 2025 | $28.1B | +11% |
| Q2 2025 | $26.5B | +4.3% |
| Q1 2025 | $27.4B | +6% |
| Q4 2024 | $25.3B | +15% |
BAC has the edge over WRB on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 30% | -3.7 points |
| Q2 2026 | 37% | +7.6 points |
| Q1 2026 | 34% | +4.7 points |
| Q4 2025 | 40% | +12 points |
| Q3 2025 | 34% | +4.8 points |
| Q2 2025 | 29% | -0.7 points |
| Q1 2025 | 30% | +1.5 points |
| Q4 2024 | 28% | +14 points |
BAC has the edge over WRB on profitability, with a higher operating margin.
WRB Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $3.7B | -0.8% |
| Q2 2026 | $3.7B | +1.2% |
| Q1 2026 | $3.7B | +4% |
| Q4 2025 | $3.7B | +1.5% |
| Q3 2025 | $3.8B | +11% |
| Q2 2025 | $3.7B | +11% |
| Q1 2025 | $3.5B | +8.9% |
| Q4 2024 | $3.7B | +14% |
WRB's revenue has held roughly level: $3.7B last quarter, about level with the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 15% | -1.8 points |
| Q2 2026 | 15% | +1.3 points |
| Q1 2026 | 17% | +1.5 points |
| Q4 2025 | 15% | -4.5 points |
| Q3 2025 | 17% | +3.3 points |
| Q2 2025 | 14% | -0.5 points |
| Q1 2025 | 15% | -2.4 points |
| Q4 2024 | 20% | +4.3 points |
WRB's operating margin was 15% last quarter, down 1.8 points from the same quarter a year ago.
BAC Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$6.5B | -114% |
| Q2 2026 | $29B | +$38.2B |
| Q1 2026 | $41.8B | +$44B |
| Q4 2025 | -$22.9B | -189% |
| Q3 2025 | $46.9B | +$84.2B |
| Q2 2025 | -$9.1B | -150% |
| Q1 2025 | -$2.2B | +$13.4B |
| Q4 2024 | $25.9B | -21% |
BAC has the edge over WRB on cash flow, with more consistent year-over-year improvement.
WRB Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $731.3M | -36% |
| Q2 2026 | $800M | +14% |
| Q1 2026 | $667.9M | -10% |
| Q4 2025 | $995.1M | +23% |
| Q3 2025 | $1.1B | -8.1% |
| Q2 2025 | $703.8M | -20% |
| Q1 2025 | $743.8M | -0.3% |
| Q4 2024 | $810M | +16% |
WRB's free cash flow was $3.2B over the past year, down 6% from the year before. Free cash flow isn't a meaningful measure for financial services companies like WRB.
BAC Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1% | -72M shares |
| 1 year | -5.3% | -405M shares |
| 3 years | -11% | -854M shares |
| 5 years | -15% | -1.3B shares |
| Available history | -24% | -2.2B shares |
BAC has the edge over WRB on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $6B |
| Q2 2026 | $6B |
| Q1 2026 | $7.2B |
| Q4 2025 | $6.3B |
| Q3 2025 | $5.3B |
| Q2 2025 | $5.3B |
| Q1 2025 | $4.5B |
| Q4 2024 | $3.5B |
BAC spent $25.6B buying back its own shares over the past year, up 37% from the year before.
WRB Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.1% | -467K shares |
| 1 year | -2.2% | -8.9M shares |
| 3 years | -5.9% | -24.7M shares |
| 5 years | -7.4% | -31.4M shares |
WRB has 391M diluted shares, down 2.2% from a year ago, with $631M in buybacks over the past year.
| Quarter | Spent |
|---|---|
| Q3 2026 | $21.1M |
| Q2 2026 | $111.5M |
| Q1 2026 | $302.4M |
| Q4 2025 | $196.4M |
| Q3 2025 | $24.6M |
| Q2 2025 | — |
| Q1 2025 | $49.2M |
| Q4 2024 | $67.4M |
WRB spent $631M buying back its own shares over the past year, about four times what it spent the year before.
BAC Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 6.4x | High |
| Q2 2026 | 6.7x | High |
| Q1 2026 | 7.1x | High |
| Q4 2025 | 7.7x | High |
| Q3 2025 | 8.3x | High |
| Q2 2025 | 8.8x | High |
| Q1 2025 | 8.6x | High |
| Q4 2024 | 9.0x | High |
BAC's net debt is about 6.4 years of its operating earnings (EBITDA), down from 8.3 years a year ago. Net leverage isn't a meaningful measure for financial services companies like BAC.
WRB Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.9x | Net Cash |
| Q2 2026 | -1.1x | Net Cash |
| Q1 2026 | -1.0x | Net Cash |
| Q4 2025 | -1.1x | Net Cash |
| Q3 2025 | -1.0x | Net Cash |
| Q2 2025 | -0.9x | Net Cash |
| Q1 2025 | -0.7x | Net Cash |
| Q4 2024 | -0.8x | Net Cash |
WRB has the edge over BAC on leverage, with a lower net debt burden relative to earnings.
BAC Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 37.1 | Neutral |
| Stochastic | 4.9 | Oversold |
BAC's weekly RSI is 37 (neutral) and its Stochastic is 5 (oversold).
WRB Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 63.4 | Neutral |
| Stochastic | 73.6 | Neutral |
WRB's weekly RSI is 63 (neutral) and its Stochastic is 74 (neutral).
BAC PE vs Financial Services Sector
| Metric | BAC | Sector median | Relative |
|---|---|---|---|
| PE | 12x | 13x | 7.5% below |
| PE % | 40 | 63 | 23 pts below |
BAC has the edge over WRB on valuation relative to its sector.
WRB PE vs Financial Services Sector
| Metric | WRB | Sector median | Relative |
|---|---|---|---|
| PE | 16x | 13x | 25% above |
| PE % | 66 | 63 | 3 pts above |
WRB is trading at 16x earnings, a 25% premium to the Financial Services sector's median of 13x.
BAC Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $52.1 | 3% below |
| 20 week MA | $57.8 | 13% below |
| 50 week MA | $54.7 | 7.7% below |
| 100 week MA | $50.5 | 0% below |
| 200 week MA | $42.5 | 19% above |
BAC has fallen below most of its moving averages, though it's still 19% above its 200-week average.
WRB Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $72.8 | 5.9% above |
| 20 week MA | $71.7 | 7.5% above |
| 50 week MA | $69.5 | 11% above |
| 100 week MA | $69.3 | 11% above |
| 200 week MA | $59.3 | 30% above |
WRB has the edge over BAC on trend strength, trading above more of its moving averages.
BAC Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $35.4 | $30.0 | -15% |
| 2021 | $30.0 | $44.4 | +48% |
| 2022 | $44.4 | $32.5 | -27% |
| 2023 | $32.5 | $33.7 | +3.7% |
| 2024 | $33.7 | $44.3 | +32% |
| 2025 | $44.3 | $56.2 | +27% |
| 2026 YTD | $56.2 | $50.5 | -10% |
BAC has finished higher in four of the last six years. It's down 10% so far in 2026.
WRB Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $30.5 | $29.4 | -3.6% |
| 2021 | $29.4 | $35.6 | +21% |
| 2022 | $35.6 | $49.0 | +37% |
| 2023 | $49.0 | $47.2 | -3.7% |
| 2024 | $47.2 | $59.0 | +25% |
| 2025 | $59.0 | $70.6 | +20% |
| 2026 YTD | $70.6 | $77.2 | +9.3% |
WRB has the edge over BAC on returns for 2026, with the stronger performance.